 |
Cystic fibrosis Tr gene therapy (recombinant adenovirus) |
|---|---|
| Trade Name | Adgvcftr.10 |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1995-03-09 00:00:00 |
| Sponsor | GenVec, Inc.;12111 Parklawn Drive;Rockville, Maryland, 20852 |
Related Access Program